Wolverine Trading’s aTyr Pharma ATYR Stock Holding History

Wolverine Trading’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$110K	Buy	+138,900	New	+$629K	﹤0.01%	5172
2025 Q2	–	Sell	-17,500	Closed	-$54.8K	–	5767
2025 Q1	$54.8K	Buy	17,500 +4,200	+32%	+$15.3K	﹤0.01%	4401
2024 Q4	$46.7K	Buy	+13,300	New	+$40.3K	﹤0.01%	5001
2023 Q1	–	Sell	-33,300	Closed	-$73K	–	5091
2022 Q4	$73K	Buy	+33,300	New	+$78.5K	﹤0.01%	3502
2022 Q2	–	Sell	-35,700	Closed	-$195K	–	5934
2022 Q1	$195K	Buy	+35,700	New	+$202K	﹤0.01%	4452
2021 Q4	–	Sell	-18,000	Closed	-$160K	–	7040
2021 Q3	$160K	Buy	+18,000	New	+$108K	﹤0.01%	5508

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's ATYR Position: Q3 2025 in Review

Wolverine Trading opened a new position in aTyr Pharma (ATYR) in Q3 2025: 54,026 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #5448 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in ATYR as recently as Q1 2025.

Wolverine Trading first reported a position in ATYR in Q1 2022 and has held it in 5 quarters since. The position peaked at $142K in Q1 2025. 103 funds tracked by Wall St. Rank hold ATYR as of Q3 2025.

Wolverine Trading held 54,026 shares of aTyr Pharma worth $43K as of Q3 2025.
aTyr Pharma was a new Wolverine Trading position in Q3 2025.
aTyr Pharma made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5448 holding.
Wolverine Trading first reported a position in aTyr Pharma in Q1 2022 and has held it in 5 quarters since.
Wolverine Trading's aTyr Pharma position peaked at $142K in Q1 2025.
103 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.